Tag: rejects
UK medical group rejects key skin cancer treatment
by on Oct.14, 2011, under Health and Fitness
An independent British medical watchdog says the first treatment proven to help people with the deadliest form of skin cancer live longer is too expensive.
View full post on Yahoo! Health News
Samsung study rejects claims semiconductor plants caused cancers
by on Jul.14, 2011, under Health and Fitness
A study commissioned by Samsung Electronics rejected assertions that employees may have been exposed to carcinogenic chemicals at its plants, as several cancer-stricken former employees of the world's top memory chipmaker seek compensation for…
View full post on Yahoo! Health News
Merck says US rejects its MS drug
by on Mar.02, 2011, under Health and Fitness
German pharmaceutical group Merck KgaA said Wednesday that the US Food and Drug Administration (FDA) has refused to approve use of its multiple sclerosis treatment Cladribine.
View full post on Yahoo! Health News
S.Korea court rejects first tobacco lawsuit
by on Feb.15, 2011, under Health and Fitness
An appeals court on Tuesday rejected South Korea's first lawsuit against a tobacco company following a 12-year legal battle by lung cancer sufferers and their families.
View full post on Yahoo! Health News
FDA rejects highly-anticipated diet drug Qnexa
by on Oct.29, 2010, under Health and Fitness
Federal health regulators have decided not to approve an experimental diet pill called Qnexa, which had been touted by many experts as the most promising weight-loss drug in more than a decade.
View full post on Yahoo! Health News
Genzyme rejects Sanofi offer as long battle looms
by on Aug.31, 2010, under Health and Fitness
Biotech company Genzyme Inc rejected an $18.5 billion buyout offer from French drugmaker Sanofi-Aventis SA on Monday, setting the stage for a protracted and potentially hostile takeover battle.
View full post on Yahoo! Health News
UK's NICE rejects Glaxo, Genmab leukemia drug
by on Jul.02, 2010, under Health and Fitness
GlaxoSmithKline leukemia drug Arzerra, licensed from Denmark's Genmab, has been rejected by Britain's cost watchdog NICE in preliminary draft guidance.
View full post on Yahoo! Health News
